SEC 13F Intelligence

Nuance Investments, LLC / GMED

Nuance Investments, LLC’s Globus Med Inc Position

Does Nuance Investments, LLC own Globus Med Inc (GMED)? Not currently — the last reported position was 3.62M shares worth $180M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$180M
Q3 2023
Shares
3.62M
% of Portfolio
+4.40%
Quarters Held
17
position exited

Position History GMED

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $16MQ2 ’19: $56MQ3 ’19: $44MQ3 ’19Q4 ’19: $8MQ1 ’20: $66MQ2 ’20: $56MQ2 ’20Q3 ’20: $53MQ4 ’20: $11MQ1 ’21: $30MQ1 ’21Q2 ’21: $17MQ2 ’22: $209,000Q3 ’22: $506,000Q3 ’22Q4 ’22: $880,471Q1 ’23: $105MQ2 ’23: $158MQ2 ’23Q3 ’23: $180Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20233.62M$180M+4.40%
Q2 20232.65M$158M+3.37%
Q1 20231.85M$105M+2.22%
Q4 202211.9K$880,471+0.02%
Q3 20228.5K$506,000+0.01%
Q2 20223.7K$209,0000.00%
Q2 2021217.4K$17M+0.30%
Q1 2021486.3K$30M+0.56%
Q4 2020169.1K$11M+0.21%
Q3 20201.07M$53M+1.25%
Q2 20201.18M$56M+1.46%
Q1 20201.55M$66M+2.28%
Q4 2019129.6K$8M+0.25%
Q3 2019865.9K$44M+1.67%
Q2 20191.32M$56M+2.36%
Q1 2019323.0K$16M+0.83%
Q4 2018124.6K$5M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nuance Investments, LLC’s full portfolio or all institutional holders of GMED.